The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

Los Angeles Superior Court Judge Carl J. West was appointed by the California Judicial Counsel to be the Coordination Motion Judge during pretrial proceedings in all product liability complaints involving Actos and bladder cancer.

This means that all Actos bladder cancer lawsuits filed in California state court, will be consolidated and coordinated during pretrial proceedings.

Federal MDL Consolidation in Louisiana

Recently consolidation was ordered for the Actos litigation pending in the federal court system, with a multidistrict litigation established in the U.S. District Court for the Western District of Louisiana.

Takeda Vows to Fight CA State Consolidation

Takeda Pharmaceuticals, the manufacturer of Actos, has indicated it intends to file a motion to transfer all of the California state court lawsuits over Actos to the federal MDL.

Lawyers representing plaintiffs who have brought the cases in California maintain that there is a legitimate basis for keeping the cases in state court, as Takeda operates a facility in San Diego.

Actos Problem

Actos (pioglitazone) was approved by the FDA to treat Type 2 Diabetes in July, 1999. It is a once-a-day pill that increases the body’s sensitivity to insulin. The medication has grown in popularity in recent years, generating $4.3 billion in sales last year.

FDA Investigates Bladder Cancer Link

FDA officials began reviewing the potential risk of Actos bladder cancer problems in September 2010, after interim data from an on-going 10 year study found that users may face an increased risk the longer they take the drug. Both France and Germany have already instituted an Actos recall, and the drug has seen increased label warnings in the U.S. and across the rest of the European Union.

Plaintiff Allegations

All of the lawsuits over Actos and bladder cancer include similar allegations, that Takeda concealed their knowledge that users may face an increased risk of bladder cancer and failed to provide adequate warnings to consumers or the medical community.

Read more here and visit my website

Comments are closed.

Of Interest